Emerging applications of stereotactic body radiotherapy

Simon S. Lo, Andrew Loblaw, Eric L. Chang, Nina A. Mayr, Bin S. Teh, Zhibin Huang, Min Yao, Rodney J. Ellis, Tithi Biswas, Jason W. Sohn, Mitchell Machtay, Arjun Sahgal

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Stereotactic body radiotherapy (SBRT) has been used extensively in patients with lung, liver and spinal tumors, and the treatment outcomes are very favorable. For certain conditions such as medically inoperable stage I non-small-cell lung cancer, liver and lung oligometastases, primary liver cancer and spinal metastases, SBRT is regarded as one of the standard therapies. In the recent years, the use of SBRT has been extended to other disease conditions and sites such as recurrent head and neck cancer, renal cell carcinoma, prostate cancer, adrenal metastasis, pancreatic cancer, gynecological malignancies, spinal cord compression, breast cancer, and stage II-III non-small-cell lung cancer. Preliminary data in the literature show promising results but the follow-up intervals are short for most studies. This paper will provide an overview of these emerging applications.

Original languageEnglish (US)
Pages (from-to)1299-1310
Number of pages12
JournalFuture Oncology
Issue number7
StatePublished - May 2014

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Emerging applications of stereotactic body radiotherapy'. Together they form a unique fingerprint.

Cite this